COVID-19 and mucormycosis in Latin America – An emerging concern

dc.contributor.authorAlfonso J. Rodríguez‐Morales
dc.contributor.authorCarlos S. Mamani-García
dc.contributor.authorJaneth N. Nuñez-Lupaca
dc.contributor.authorDarwin A. León‐Figueroa
dc.contributor.authorMely Olarte-Durand
dc.contributor.authorRobinson A. Yrene-Cubas
dc.contributor.authorDiana Manuela Ticona
dc.contributor.authorSebastian Abanto-Urbano
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T21:15:35Z
dc.date.available2026-03-22T21:15:35Z
dc.date.issued2021
dc.descriptionCitaciones: 8
dc.identifier.doi10.1016/j.tmaid.2021.102156
dc.identifier.urihttps://doi.org/10.1016/j.tmaid.2021.102156
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/86879
dc.language.isoen
dc.publisherElsevier BV
dc.relation.ispartofTravel Medicine and Infectious Disease
dc.sourceUniversidad Científica del Sur
dc.subjectCoronavirus disease 2019 (COVID-19)
dc.subjectMucormycosis
dc.subjectLatin Americans
dc.subject2019-20 coronavirus outbreak
dc.subjectSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
dc.subjectPandemic
dc.subjectBetacoronavirus
dc.subjectVirology
dc.subjectMedicine
dc.subjectMEDLINE
dc.titleCOVID-19 and mucormycosis in Latin America – An emerging concern
dc.typeletter

Files